1. Introduction {#sec1}
===============

Mesenchymal stem cells (MSCs) have attracted a great deal of interest because of their potential application in regenerative medicine and tissue engineering. MSCs are highly proliferative and adherent fibrotic cells that express characteristic cell surface markers and retain self-renewing capacity with the potential of differentiating into various tissues including bone, muscle, cartilage, fat, and nerve \[[@B1]\]. MSCs may be isolated readily from several tissues such as bone marrow, adipose tissue, and placenta \[[@B2]\]. Although MSCs derived from bone marrow are well characterized, the harvest of stem cells from the bone marrow is a highly invasive procedure with a considerable risk of donor site morbidity.

Recently, potential alternative sources of MSCs and nonaggressive methods for the harvesting of stem cells have been investigated; in particular, the umbilical cord (UC) and dental pulp (DP) show great promise as source tissues because they contain a considerable number of cells with properties similar to those of MSCs \[[@B3], [@B4]\]. In recent years, UC-MSCs have shown an odontogenic differentiation potential to differentiate into odontoblast-like cells in an odontogenic microenvironment \[[@B5]\].

UC tissue (Wharton\'s jelly of human umbilical cord) is considered an ideal source of stem cells with characteristics similar to those of MSCs from bone marrow and adipose tissue, for example, fibroblast morphology, surface protein markers, and potential for differentiation into cells of therapeutic value \[[@B6], [@B7]\]. UC cells exhibit immunosuppressive capacity and high proliferation rates, which are useful in allogeneic environments \[[@B8], [@B9]\]. DP, which is thought to be derived from migratory neural crest cells during development, is a source of various populations of multipotent stem cells \[[@B10]\]. Similar to MSCs, dental pulp stem cells (DPSCs) are adherent clonogenic cells with varying capacities for differentiation along mesenchymal or nonmesenchymal lineages \[[@B11]\].

The UC is a potentially valuable source of MSCs as the isolation process is noninvasive and causes no harm to the mother or infant and utilizes material that is usually discarded \[[@B12]\]. In addition, UC tissue is derived from the neonate and is therefore less mature than adult tissues. This lowers the risk of immune reactions during donor transplantation. DPSCs also represent a valuable source of MSCs, as the latter may be obtained with minimal pain and morbidity \[[@B13]\]. Therefore, MSCs derived from the UC and DP are more desirable for stem cell-based therapy than stem cells obtained from conventional sources such as bone marrow.

Despite extensive knowledge of the properties of UC-MSCs and DPSCs, it is still not known whether their properties accurately reflect their true gene expression patterns and developmental potential in situ. The fate of stem cells is regulated by cell-intrinsic determinants and signals within a specialized microenvironment \[[@B14]\]. Therefore, investigation of the genes related to stemness in UC and DP is necessary in order to evaluate the potential value of these tissues as alternative sources of MSCs. In particular, their gene expression patterns must be analyzed to obtain insights into the differentiation capacity of the stem cells and to compare the biological functions of the stemness-related genes in terms of interactions with the microenvironment. In this study, we performed a DNA microarray-based differential gene expression analysis of UC and DP tissues with the aim of comparing the characteristics of MSCs from each type of tissue.

2. Materials and Methods {#sec2}
========================

2.1. Tissue Samples {#sec2.1}
-------------------

The experimental protocol was approved by the Institutional Review Board of Yonsei University Dental Hospital (\#2-2012-0001) and Severance Hospital (\#4-2012-0408). All the subjects or their guardians have provided written informed consent. Pulp samples were obtained from healthy permanent premolars (*n* = 25; from 5 males and 6 females, aged 11--25 years) extracted for orthodontic reasons. The fresh umbilical cord tissues were obtained from three newborns in the Department of Obstetrics and Gynecology, Severance Hospital, Yonsei University. The extracted teeth and umbilical cords were frozen immediately and stored in liquid nitrogen. The pulp tissue was obtained using sterile tweezers and barbed broaches. The UC tissue was sliced at a thickness of 10--14 *μ*m using a cryostat (CM3050S, Leica Biosystems, Newcastle Upon Tyne, UK). Subsequently, the DP and UC tissues were immediately submerged in Buffer RLT, which is a proprietary component of the RNeasy Fibrous Mini Kit® (Qiagen, Valencia, CA, USA).

2.2. RNA Extraction {#sec2.2}
-------------------

We used similar study procedures applied by Song et al. \[[@B15]\], Lee et al. \[[@B16]\], and Kim et al. \[[@B17]\]. Total RNA was extracted from DP and UC tissues using the RNeasy Fibrous Mini Kit (Qiagen) according to the manufacturer\'s instructions. The extracted RNA was eluted in 25 *μ*L of sterile water. Prior to RNA extraction, tissues were homogenized using a Bullet Blender® Bead (Next Advanced, Averill Park, NY, USA). RNA concentrations were determined from absorbance values at a wavelength of 260 nm using a spectrophotometer (Nanodrop ND-1000®, Thermo Scientific, Waltham, MA, USA). RNA samples used in this study had 260/280 nm ratios equal to or greater than 1.8.

2.3. cDNA Microarray {#sec2.3}
--------------------

Global gene expression analyses were performed using GeneChip® Human Gene 1.0 ST oligonucleotide arrays (Affymetrix, Santa Clara, CA, USA). The average amount of RNA isolated from DP and UC tissues was 1 *μ*g. Total RNA was isolated using the RNeasy Fibrous Mini Kit columns as described by the manufacturer (Qiagen). RNA quality was assessed using the Agilent 2100 Bioanalyzer with an RNA 6000 Nano Chip® (Agilent Technologies, Amstelveen, Netherlands). RNA quantity was determined using the Nanodrop ND-1000. Each RNA sample was subjected to global gene expression analysis according to the manufacturer\'s protocol (<http://www.affymetrix.com/>). Briefly, 300 ng of total RNA from each sample was converted to double-stranded cDNA. Using a random hexamer incorporating a T7 promoter, amplified RNA (cRNA) was generated from the double-stranded cDNA template via an in vitro transcription reaction and was purified using the Affymetrix sample cleanup module. cDNA was generated by random-primer reverse transcription using a dNTP mix containing dUTP. The cDNA was then fragmented using the restriction endonucleases uracil-DNA glycosylase and human apurinic/apyrimidinic endonuclease. Next, the fragmented cDNA was end-labeled via a terminal transferase reaction incorporating a biotinylated dideoxynucleotide. Fragmented end-labeled cDNA was hybridized to the GeneChip Human Gene 1.0 ST array for 16 h at 45°C and 60 rpm as described in the GeneChip Whole Transcript Sense Target Labeling Assay Manual (Affymetrix). After hybridization, the chips were stained and washed in a GeneChip Fluidics Station 450 and scanned using a GeneChip Array scanner 3000 G7 (Affymetrix). The image data were extracted using Command Console software 1.1 (Affymetrix) and a raw file containing the expression intensity data was generated and used for the next step. This microarray data set was approved by the Gene Expression Omnibus (GEO) (<https://www.ncbi.nlm.nih.gov/geo/>); the GEO accession numbers of the data set are GSE75642 (umbilical cord) and GSE75644 (dental pulp).

2.4. Gene Ontology Analysis {#sec2.4}
---------------------------

Expression data were generated using Expression Console software version 1.1 (Affymetrix). For normalization, the Robust Multiarray Average algorithm of the Expression Console software was used. In order to determine whether genes were differentially expressed in the three groups, a one-way ANOVA was performed on the Robust Multiarray Average expression values. A multiple testing correction was applied to the *p* values of the *F*-statistics to adjust the false discovery rate. Genes with adjusted *F*-statistic *p* values \< 0.05 were extracted. Highly expressed genes that showed over 2-fold differences between the signal values in the control and each test group were selected for further investigation. In order to classify the coexpression gene group with a similar expression pattern, we performed hierarchical and *K*-mean clustering using MultiExperiment Viewer software 4.4 (<http://www.tm4.org/>, Dana-Farber Cancer Institute, Boston, MA, USA). The web-based tool, DAVID (the Database for Annotation, Visualization, and Integrated Discovery), was used for biological interpretation of differentially expressed genes. Subsequently, these genes were classified based on their function according to the KEGG Pathway database (<https://david.ncifcrf.gov/home.jsp>).

2.5. Quantitative Reverse Transcription Polymerase Chain Reaction {#sec2.5}
-----------------------------------------------------------------

The single-stranded cDNA required in the PCR analysis step was produced using 500 ng of extracted total RNA as a template for reverse transcription (Superscript III Reverse Transcriptase and Random Primer, Invitrogen, Paisley, UK). The reverse transcription reaction was performed at 65°C for 5 minutes, followed by 25°C for 5 minutes, 50°C for 1 hour, and 70°C for 15 minutes to inactivate the reverse transcriptase. The synthesized cDNA was diluted 10 : 1 in distilled water and used as a template for qRT-PCR, which was performed using the ABI7300 RT-PCR system (Applied Biosystems, Warrington, UK). Samples of 25 *μ*L containing 1x Universal TaqMan Master Mix (4369016, Applied Biosystems), PCR primers at a concentration of 0.9 *μ*M, and the diluted cDNA were prepared in triplicate. The amplification conditions were 50°C for 2 minutes and 95°C for 10 minutes followed by 40 cycles of 95°C for 15 seconds and 60°C for 1 minute. TaqMan gene expression assay primers (Applied Biosystems) were used. The primers for each gene are listed in [Table 1](#tab1){ref-type="table"}. ABI 7300 SDS 1.3.1 software (Applied Biosystems) was used to record the fluorescence intensity of the reporter and quencher dyes. Fluorescence intensity values were plotted against time and quantified as the cycle number. A precise quantification of the initial target was obtained by examining the amplification plots during the early log phase of product accumulation above background (the threshold cycle (Ct) number). Ct values were subsequently used to determine ΔCt values (ΔCt = Ct of the gene minus Ct of the 18S rRNA gene control), and differences in Ct values were used to quantify the relative amount of PCR product, expressed as the relative change by applying the equation 2^−ΔCt^. The specific primer assay ID and product sizes for each gene are listed in [Table 1](#tab1){ref-type="table"}.

2.6. Immunohistochemical Staining {#sec2.6}
---------------------------------

For IHC staining, tissues from permanent teeth and the UC were fixed in 10% buffered formalin (Sigma-Aldrich, St. Louis, MO, USA) for 1 day. Permanent teeth were decalcified using 10% EDTA (pH 7.4; Thermo Fisher Scientific, Houston, TX, USA) for 8 weeks. The permanent teeth and UC tissues were embedded in paraffin and sectioned at a thickness of 3 *μ*m. Specimens were subjected to IHC staining with antibodies against DSPP (rabbit polyclonal, diluted 1 : 1500; sc-33586, Santa Cruz Biotechnology, Santa Cruz, CA, USA), DMP1 (rabbit polyclonal, diluted 1 : 100; Ab82351, Abcam), CALB1 (rabbit polyclonal, diluted 1 : 400; Ab25085, Abcam), and CD146 (MCAM, rabbit polyclonal, diluted 1 : 400; Ab75769, Abcam). Endogenous peroxidase activity was quenched by the addition of 3% hydrogen peroxide. Sections were incubated in 5% bovine serum albumin to block nonspecific binding. The primary antibodies were diluted to obtain optimal staining and sections were incubated overnight. After incubation, the EnVision+ System-HRP Labeled Polymer Anti-Rabbit kit (K4003, Dako, Carpinteria, CA, USA; ready to use) was applied for 20 minutes. Color development was performed using labeled streptavidin biotin kits (Dako) according to the manufacturer\'s instructions. The sections were counterstained with Gill\'s hematoxylin (Sigma-Aldrich). Control sections were treated in the same manner but without primary antibodies.

3. Results {#sec3}
==========

3.1. Gene Expression Profiles of UC and DP Tissues {#sec3.1}
--------------------------------------------------

Complementary DNA microarray technology was used to compare multiple gene expression profiles representative of DP and UC tissues. In order to investigate these differentially expressed genes further, data with a more stringent threshold of 3-fold differential expression were filtered to ensure biological significance. The results indicated that 1,957 out of 33,297 (5.88%) genes exhibited an absolute expression change at least 3-fold. The expression levels of 988 genes were 3-fold higher in the UC than in DP tissues, while the expression levels of 969 genes were at least 3-fold higher in DP than in UC tissues. The data were further filtered, and the genes are listed in Tables [2](#tab2){ref-type="table"} and [3](#tab3){ref-type="table"} according to their biological functions.

3.2. Gene Ontology Analysis {#sec3.2}
---------------------------

In the UC tissue, the expression levels of 158 genes were upregulated 10-fold or more in comparison with DP, whereas the expression levels of 118 genes were upregulated 10-fold in DP in comparison with UC. Genes related to cell proliferation and angiogenesis were expressed at higher levels in UC than in DP. Lipid metabolic process-related genes were highly expressed in DP. In comparison with DP, a large proportion of the UC genes were related to growth factor activity, structural molecular activity, DNA binding, and protein binding ([Figure 1](#fig1){ref-type="fig"}).

3.3. Stemness Characterization Using Surface Protein Markers {#sec3.3}
------------------------------------------------------------

The comparative expression results for MSC surface protein markers are indicated in [Figure 3](#fig3){ref-type="fig"}. UC tissue appeared to contain a population of cells that were more positive for MSC markers (including*CD29*,*CD34*,*CD44*,*CD73*,*CD105*,*CD146*, and*CD166*) according to the minimal criteria of the International Society for Cell Therapy \[[@B18]\]. The comparative expression analysis of four induced pluripotent stem cell (iPSC) marker genes (i.e.,*OCT4*,*SOX2*,*MYC*, and*KLF4*) revealed that the expression level of these genes was the same in UC and DP. qRT-PCR analysis for eight important marker genes revealed four tooth-related genes (*DSPP*,*AMBN*,*CALB1*, and*DMP1*), three genes for MSCs (*CD34*,*CD146*, and*CD166*), and MYC related to iPSC stemness. DSPP, AMBN, CALB1, and DMP1 were expressed in DP tissue but they were not excluded in the comparative qPCR results because they were not detected in UC tissue. The expression levels of CD146, CD166, and MYC were 18.3, 8.24, and 1.63 times higher, respectively, in UC than in DP, and the expression level of CD34 was 2.15 times higher in DP than in UC ([Figure 2](#fig2){ref-type="fig"}).

3.4. Immunohistochemical Staining {#sec3.4}
---------------------------------

MCAM (CD146) was expressed abundantly as a perivascular stem cell marker in connective tissue, especially in the arteries of the UC. However, this protein showed a very low level of expression in DP tissue ([Figure 3](#fig3){ref-type="fig"}). IHC staining showed that DSPP, DMP1, and CALB1 were expressed broadly in DP tissue ([Figure 4](#fig4){ref-type="fig"}), but barely expressed in the UC. DSPP was evident in pulpal tissue, the odontoblast layer, and primary and secondary dentin. While DMP was stained in the odontoblast layer and secondary dentin, CALB1 was expressed in pulpal tissue and the odontoblast layer. These findings were consistent with the microarray data.

4. Discussion {#sec4}
=============

Although numerous studies have been performed to evaluate the utility of human MSCs as sources for the development of cell-based therapeutics, a precise understanding of the biology of MSCs remains elusive. Previous studies, based on a strict definition of MSCs at the molecular or cellular levels, involved serial analyses of gene expression. However, such approaches raised concerns that the expression of housekeeping genes may have interfered with the identification of MSC-specific genetic characteristics. To overcome such shortcomings, we examined DNA microarray-based differential expression profiles of MSC population, comparing these profiles with those of other tissues to evaluate stemness capacity. We compared DP with UC tissue as both types contain stromal stem cell populations with high proliferative potential that are capable of regenerating their respective microenvironments with remarkable fidelity \[[@B19]\]. In order to identify genes expressed at higher levels in UC than in DP tissue, we categorized genes according to the ratio of the fold change between the two tissues. Results of qRT-PCR and IHC staining analyses confirmed the validity of these data, indicating that the expression of representative genes was consistent with the differential expression patterns observed in the microarray data.

Although MSCs originating from both tissues are highly similar, their differences may be functionally related to their origin; for example, MSCs derived from DP are more committed to the osteoblastic and odontogenic lineages, whereas MSCs derived from the UC would be more committed to angiogenesis. In DP tissue, microarray results indicated that certain genes (*DMP1*,*AMBN*,*DSPP*,*DLX1*,*RUNX2*,*LEF1*,*PAX9*, and*MSX1*) related to odontogenesis and biomineral tissue development were upregulated, which was in agreement with the expected results for this biological process. In addition, genes that might be related to bone and dentin mineralization, including*PHEX*,*CALB1*,*MMP20*,*ALPL*,*LHX8*, and*WNT10A*, were upregulated. Microarray data showed that the expression of*DMP1*,*DSPP*, and*CALB* that play important roles in the development of pulp tissue was 99.2, 98.1, and 41.3 times higher, respectively, in DP than in UC. qRT-PCR results indicated that the fold differences in the expression of*DMP1*,*CALB1*, and*AMBN* were not observed in the UC. Similarly, IHC staining results showed that*DMP1*,*CALB1*, and*DSPP* were not stained in the UC but were stained around the outer area of DP. The genetic pattern analysis of permanent pulp indicated that*CALB1*, a representative gene in DP, is necessary for enamel mineralization in transition- and maturation-stage ameloblasts \[[@B17]\].

MSCs possess multilineage differentiation potential with a variety of chemokines, cytokines, and growth factors involved in the regeneration of damaged tissue. They are capable of modifying their molecular activities and functions in response to the environment. The exclusive expression of the chemokines CXCL1 and CXCL6 in the UC may increase propagation of hematopoietic precursors in coculture settings. Other genes expressed at higher levels in the UC include those encoding IL-6, IL-18, FGF9, FGF10, PDGFA, EGF, and VEGFA, which are part of interconnected pathways related to angiogenesis. Jin et al. reported that MSCs derived from bone marrow, adipose tissue, and the UC have significantly different anti-inflammatory capacities and confirmed that UC-MSCs exhibit the greatest anti-inflammatory effects \[[@B20]\]. These findings suggest that UC-MSCs are more efficient for clinical applications involving revascularization.

In this study, the comparison of stemness of UC and DP tissues revealed no significant fold difference in the expression of several surface markers (CD29, CD34, CD44, CD73, CD105, and CD106) typical for MSCs. Nevertheless, some differences were observed in the expression level of CD146 (MCAM) and CD166 (ALCAM), which connect the control of cell growth with cell migration. These findings are representative of the developmental process. The qRT-PCR results showed that the expression levels of CD146 and CD166 were higher in UC than in DP (18.3-fold and 8.24-fold, resp.). These molecular differences in tissue-specific MSC gene expression may reflect their functional activities in distinct niches. A study utilizing flow cytometry reported higher expression of CD146, a marker expressed on both BMSCs and DP-MSCs \[[@B21]\]. IHC data confirmed that CD146 is a marker of vascular endothelial cells expressed on arteries of the UC and the outer walls of blood vessels in DP, suggesting that the majority of stem cells arise from the microvasculature. Accumulating evidence suggests that the expression of CD166 reflects the onset of a cellular program involving neural development, branching organ development, hematopoiesis, the immune response, and tumor progression \[[@B22]\]. Struys et al. reported that cultured DPSCs and UC-MSCs showed a similar expression pattern of antigens characteristic of MSCs such as CD105, CD29, CD44, CD146, and STRO-1 \[[@B23]\]. DPSCs are also identified by their positive expression of CD29, CD44, CD73, CD90, CD105, and STRO-1 \[[@B19]\]. CD34 protein is a specific antigen in hematopoietic cells, indicating that a greater number of immature hematopoietic cells are present in both UC and DP \[[@B24]\]. CD34 is present on the outer cell walls of DP and in the connective tissue of the UC, in agreement with previous studies reporting that CD34 localizes on large blood vessels, but not capillaries \[[@B25]\].

The expression of pluripotent stem cell genes in the UC and DP might reflect their embryonic origin. iPSCs are the most promising cell source for cell-based therapy in regenerative medicine, as they give rise to development by introducing 4 factors: MYC, KLF4, OCT4, and SOX2 \[[@B7]\]. No significant differences were found between the expressions of these factors in the two tissue types; MYC, KLF4, OCT4, and SOX2 were expressed 1.57, 1.03, 1.20, and 1.20 times more highly, respectively, in UC than in DP tissue. Previously, DPSCs were characterized by the low levels of expression of undifferentiated cell-associated genes, such as OCT4, MYC, and Nanog, which are considered to facilitate reprogramming \[[@B26]\]. Recent studies utilizing the UC to derive iPSCs are expected to contribute to the further expansion of its pluripotency for therapeutic purposes, including drug discovery \[[@B27], [@B28]\].

The UC expresses specific embryonic cell markers such as DLK1, DKK1, TBX18, WNT4, and TGFB3. Previous studies describing the expression of embryonic cell markers in the UC have shown that fetal perivascular cells express Runx1 and OCT-4 at different levels, which characterizes the undifferentiated stem cell state \[[@B29]\]. Interestingly, UC-MSCs exhibited higher levels of expression of genes related to cell proliferation than DPSCs, whereas DPSCs exhibited a higher proliferation rate compared with BMSCs in vitro \[[@B11]\]. Previous study revealed similar result of this research that UC-MSCs seemed to have higher cell proliferation ability, while DP-MSCs may have significant differences for lower cell apoptosis, osteogenic differentiation, and senescence \[[@B30]\]. This may be attributed to the developmental state of tissues, as UC samples are at an earlier stage of development compared with DP from fully developed and erupted permanent teeth. Commonly expressed genes in DP include those coding for various growth factors (BMP-2, BMP-5, BMP-7, MMP20, and TGF-*β*1) implicated as strong promoters of the formation of mineralized bone matrix and tooth morphogenesis \[[@B31]\]. Coexpression of genes with known functions, and unknown or novel genes, may provide a simple means to obtain data about genes for which little information is available.

Although the results of this study are still limited and require further investigation using additional methods, the similarity between MSCs derived from the UC and DP at the transcription level definitively places both tissues as potentially more accessible sources of MSCs. Furthermore, the present gene expression analysis confirms similarities between MSCs derived from the UC and DP and provides molecular and biological insights into the developmental mechanisms involved in angiogenic and odontogenic processes.

5. Conclusions {#sec5}
==============

Here, we presented comparative gene expression data for human UC and DP tissue. Although UC tissue showed similar but slightly higher expression patterns, with the usual MSC markers, both tissues clearly diverged in their differentiation capacity. Further research is necessary to understand and describe the significance of these findings for clinical applications.
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![Main categories of genes expressed specifically in umbilical cord and dental pulp classified according to their biological (a) and molecular functions (b). Genes related to cell proliferation and angiogenesis were expressed at higher levels in the UC than in DP (*p* \< 0.05).](SCI2016-3453890.001){#fig1}

![Relative gene expression of mesenchymal stem cell and induced pluripotent stem cell markers using cDNA microarray (a). The relative differences in the expression of stem cell markers between umbilical cord and dental pulp were analyzed using qRT-PCR (b). Data are presented as means ± standard deviation and expressed as the relative change by applying the equation 2^−ΔCt^, where ΔCt = Ct of the gene minus Ct of the 18S rRNA.](SCI2016-3453890.002){#fig2}

![Immunohistochemical (IHC) staining of umbilical cord tissues. IHC staining for DSPP (a, e), DMP1 (b, f), CALB1 (c, g), and CD146 (d, h). CD146 is expressed on arteries of the umbilical cord, suggesting that the majority of stem cells arise from the microvasculature. (scale bars: (a)--(d) 4 mm, (e)--(h) 200 *μ*m).](SCI2016-3453890.003){#fig3}

![Immunohistochemical (IHC) staining of dental pulp tissue. IHC staining for DSPP (a, e). DSPP was noted in pulpal tissue, the odontoblast layer, and primary and secondary dentin. IHC staining for DMP1 (b, f) and CALB1 (c, g). CALB1 was especially expressed in pulpal tissue and the odontoblast layer. IHC staining for CD146 (d, h) (scale bars: (a)--(d) 4 mm, (e)--(h) 200 *μ*m).](SCI2016-3453890.004){#fig4}

###### 

Quantitative RT-PCR primer lists.

  Gene symbol     Gene description                             Assay ID        Amplicon length
  --------------- -------------------------------------------- --------------- -----------------
  AMBN            Ameloblastin (enamel matrix protein)         Hs00212970_m1   61
  ALCAM (CD166)   Activated leukocyte cell adhesion molecule   Hs00977641_m1   103
  CALB1           Calbindin 1                                  Hs00191821_m1   90
  CD34            CD34 molecule                                Hs00990732_m1   91
  DMP1            Dentin matrix acidic phosphoprotein 1        Hs01009391_g1   106
  DSPP            Dentin sialophosphoprotein                   Hs00171962_m1   67
  MCAM (CD146)    Melanoma cell adhesion molecule              Hs00174838_m1   77
  MYC             c-Myc                                        Hs00153408_m1   107
  18S             18S rRNA                                     Hs03003631_g1   69

###### 

Representative differentially expressed genes with higher expression levels in umbilical cord than in dental pulp tissue.

  Functional category                        Gene symbol                                                                             Biological process                               Accession number   Absolute fold change
  ------------------------------------------ --------------------------------------------------------------------------------------- ------------------------------------------------ ------------------ ----------------------
  Embryonic development                      DLK1                                                                                    Embryonic skeletal system development            NM_003836          56.86
  DKK1                                       Embryonic limb morphogenesis                                                            NM_012242                                        44.51              
  SCEL                                       Epidermis development, embryo development                                               NM_144777                                        33.26              
  TBX18                                      Morphogenesis of embryonic epithelium                                                   NM_001080508                                     15.66              
  HOXD10                                     Embryonic skeletal system morphogenesis                                                 NM_002148                                        12.03              
  TBX20                                      Embryonic heart tube development                                                        NM_001077653                                     11.71              
  HOXC10                                     Embryonic limb morphogenesis                                                            NM_017409                                        8.70               
  HOXC6                                      Embryonic skeletal system development                                                   NM_004503                                        7.22               
  HAND2                                      In utero embryonic development                                                          NM_021973                                        6.54               
  HOXA6                                      Embryonic skeletal system morphogenesis                                                 NM_024014                                        5.50               
  EDN1                                       In utero embryonic development                                                          NM_001955                                        5.35               
  WNT4                                       Embryonic epithelial tube formation                                                     NM_030761                                        4.31               
  GATA6                                      In utero embryonic development                                                          NM_005257                                        4.17               
  TGFB1I1                                    Morphogenesis of embryonic epithelium                                                   NM_001042454                                     4.13               
  TGFB3                                      In utero embryonic development                                                          NM_003239                                        3.85               
  SOX5                                       In utero embryonic development                                                          NM_152989                                        3.70               
                                                                                                                                                                                                         
  Developmental process                      DES                                                                                     Cytoskeleton organization                        NM_001927          66.18
  KRT6A                                      Ectoderm development                                                                    NM_005554                                        27.69              
  KRT5                                       Epidermis development                                                                   NM_000424                                        22.73              
  KRT13                                      Epidermis development, tongue morphogenesis                                             NM_153490                                        22.53              
  COL12A1                                    Skeletal system development, collagen fibril organization                               NM_004370                                        17.87              
  DKK2                                       Multicellular organismal development                                                    NM_014421                                        12.63              
  TAGLN                                      Muscle organ development                                                                NM_001001522                                     11.91              
  KRT8                                       Cytoskeleton organization                                                               NM_002273                                        11.04              
  KRT14                                      Epidermis development                                                                   NM_000526                                        9.01               
  OSTN                                       Ossification, multicellular organismal development                                      NM_198184                                        8.22               
  MCAM                                       Anatomical structure morphogenesis                                                      NM_006500                                        7.22               
  IGF2BP3                                    Anatomical structure morphogenesis                                                      NM_006547                                        7.10               
  ADAM19                                     Fertilization, muscle development, neurogenesis                                         NM_033274                                        6.41               
  MGP                                        Cartilage condensation, ossification                                                    NM_001190839                                     5.70               
  DMD                                        Muscle organ development, skeletal muscle tissue development                            NM_000109                                        5.22               
  PITX2                                      Multicellular organismal development                                                    NM_153426                                        4.79               
                                                                                                                                                                                                         
  Physiological process                      ACTG2                                                                                   Muscle contraction                               NM_001615          115.24
  HBG1                                       Transport                                                                               NM_000559                                        101.65             
  PLN                                        Cellular calcium ion homeostasis, blood circulation                                     NM_002667                                        71.69              
  CNN1                                       Regulation of smooth muscle contraction                                                 NM_001299                                        66.37              
  HBB                                        Regulation of blood pressure, oxygen transport                                          NM_000518                                        38.48              
  FGF10                                      Angiogenesis                                                                            NM_004465                                        31.24              
  COL8A1                                     Angiogenesis                                                                            NM_001850                                        12.02              
  AHSP                                       Hemoglobin metabolic process, hematopoiesis                                             NM_016633                                        7.18               
  FGF9                                       Angiogenesis, osteoblast differentiation                                                NM_002010                                        5.07               
  PDGFA                                      Angiogenesis, response to hypoxia                                                       NM_002607                                        5.00               
  ELN                                        Respiratory gaseous exchange, blood circulation                                         NM_000501                                        4.75               
  EGF                                        Angiogenesis, positive regulation of cell proliferation                                 NM_001963                                        4.30               
  IL18                                       Angiogenesis, response to hypoxia                                                       NM_001562                                        3.85               
  VEGFA                                      Angiogenesis, ovarian follicle development                                              NM_001025366                                     3.16               
                                                                                                                                                                                                         
  Signal transduction and regulation         PRLR                                                                                    Cell surface receptor linked signaling pathway   NM_000949          90.61
  RASSF3                                     Signal transduction                                                                     NM_178169                                        12.27              
  RERG                                       GTPase mediated signal transduction                                                     NM_032918                                        11.98              
  STC2                                       Cell surface receptor linked signaling pathway                                          NM_003714                                        11.37              
  CD244                                      Signal transduction                                                                     NM_016382                                        8.83               
  ASPN                                       Negative regulation of transforming growth factor beta receptor signaling pathway       NM_017680                                        8.20               
  LPHN3                                      G-protein coupled receptor protein signaling pathway                                    NM_015236                                        7.72               
  SPSB1                                      Intracellular signaling pathway                                                         NM_025106                                        6.87               
  ALCAM                                      Signal transduction, motor axon guidance                                                NM_001627                                        3.96               
                                                                                                                                                                                                         
  Cell regulation and proliferation          UPK1B                                                                                   Epithelial cell differentiation                  NM_006952          45.66
  MYOCD                                      Cardiac cell differentiation                                                            NM_001146312                                     40.32              
  EGFL6                                      Cell differentiation                                                                    NM_015507                                        11.94              
  PODN                                       Negative regulation of cell proliferation                                               NM_153703                                        9.96               
  FAS                                        Positive regulation of necrotic cell death                                              NM_000043                                        9.34               
  KRT4                                       Epithelial cell differentiation, negative regulation of epithelial cell proliferation   NM_002272                                        6.52               
  IGFBP7                                     Regulation of cell growth                                                               NM_001553                                        6.01               
  HEMGN                                      Cell differentiation, regulation of osteoblast differentiation                          NM_018437                                        5.70               
  CDH1                                       Trophectodermal cell differentiation                                                    NM_004360                                        5.44               
  DPT                                        Cell adhesion, negative regulation of cell proliferation                                NM_001937                                        5.13               
                                                                                                                                                                                                         
  Cytokine, chemokine, and immune response   IL1RL1                                                                                  Immune response                                  NM_016232          36.22
  S100A8                                     Chemotaxis, inflammatory response                                                       NM_002964                                        26.48              
  DPP4                                       Regulation of T cell mediated immunity                                                  NM_001935                                        18.16              
  ITGB6                                      Inflammatory response                                                                   NM_000888                                        15.01              
  IGF2BP1                                    Regulation of cytokine biosynthetic process                                             NM_006546                                        9.59               
  LY96                                       Inflammatory response, cellular defense response                                        NM_015364                                        8.40               
  CCRL1                                      Chemotaxis, immune response                                                             NM_178445                                        7.81               
  ANLN                                       Cytokinesis                                                                             NM_018685                                        7.60               
  CMKLR1                                     Chemotaxis, immune response                                                             NM_001142343                                     7.41               
  CD97                                       Inflammatory response, immune response                                                  NM_078481                                        6.96               
  CXCL1                                      Chemotaxis, inflammatory response, immune response                                      NM_001511                                        5.54               
  IL33                                       Positive regulation of macrophage activation                                            NM_033439                                        5.29               
  CXCR1                                      Chemotaxis, inflammatory response                                                       NM_000634                                        3.48               
  CXCL6                                      Chemotaxis, inflammatory response                                                       NM_002993                                        3.07               

###### 

Representative differentially expressed genes with higher expression levels in dental pulp tissue than in umbilical cord.

  Functional category                        Gene symbol                                                                Biological process                                Accession number   Absolute fold change
  ------------------------------------------ -------------------------------------------------------------------------- ------------------------------------------------- ------------------ ----------------------
  Biomineral tissue development              PHEX                                                                       Bone and dentin mineralization                    NM_000444          160.01
  DMP1                                       Bone and dentin mineralization                                             NM_004407                                         99.20              
  CALB1                                      Hydroxyapatite formation                                                   NM_004929                                         98.07              
  MMP20                                      Regulation of enamel mineralization, proteolysis                           NM_004771                                         85.26              
  AMBN                                       Bone mineralization, odontogenesis of dentine-containing tooth             NM_016519                                         65.69              
  DSPP                                       Odontogenesis of dentine-containing tooth                                  NM_014208                                         41.26              
  ALPL                                       Biomineral tissue development                                              NM_000478                                         14.83              
  DLX1                                       Odontogenesis of dentine-containing tooth                                  NM_178120                                         9.55               
  LHX8                                       Odontogenesis of dentine-containing tooth                                  NM_001001933                                      7.56               
  CA2                                        Odontogenesis of dentine-containing tooth                                  NM_000067                                         7.07               
  RUNX2                                      Ossification, osteoblast differentiation                                   NM_001024630                                      6.53               
  LEF1                                       Odontogenesis of dentine-containing tooth                                  NM_016269                                         6.24               
  PAX9                                       Tooth development                                                          NM_006194                                         5.79               
  MSX1                                       Odontogenesis, craniofacial development                                    NM_002448                                         4.04               
  WNT10A                                     Regulation of odontogenesis of dentine-containing tooth                    NM_025216                                         3.87               
                                                                                                                                                                                             
  Developmental process                      DLX5                                                                       Osteoblast differentiation                        NM_005221          30.01
  DLX3                                       Multicellular organismal development                                       NM_005220                                         26.13              
  ADAM22                                     Proteolysis, central nervous system development                            NM_021723                                         25.00              
  NES                                        Central nervous system development                                         NM_006617                                         15.67              
  BMP7                                       Ossification, organ morphogenesis                                          NM_001719                                         15.60              
  BMPR1B                                     Skeletal system development, cartilage condensation                        NM_001203                                         13.53              
  MSX2                                       Skeletal system development, osteoblast differentiation                    NM_002449                                         9.32               
  COL11A2                                    Skeletal system morphogenesis, cartilage development, palate development   NM_001163771                                      8.55               
  BMP5                                       Skeletal system development, ossification                                  NM_021073                                         6.08               
  TBX3                                       Blood vessel development, in utero embryonic development                   NM_016569                                         5.93               
  MBP                                        Central nervous system development, myelination                            NM_001025101                                      4.95               
  DLX6                                       Multicellular organismal development, nervous system development           NM_005222                                         4.12               
  NRCAM                                      Axonogenesis, central nervous system development                           NM_001193582                                      4.09               
  SNAI1                                      Osteoblast differentiation, mesoderm formation                             NM_005985                                         3.78               
  HLF                                        Multicellular organismal development, rhythmic process                     NM_002126                                         3.23               
  BMP2                                       Development of bone and cartilage                                          NM_001200                                         2.11               
                                                                                                                                                                                             
  Physiological process                      TF                                                                         Controlling iron concentrations, erythropoiesis   NM_001063          153.98
  SCN7A                                      Sodium ion transport, muscle contraction                                   NM_002976                                         82.36              
  APOD                                       Lipid metabolic process                                                    NM_001647                                         41.22              
  PLAT                                       Response to hypoxia, blood coagulation                                     NM_000930                                         10.20              
  CD52                                       Elevation of cytosolic calcium ion concentration                           NM_001803                                         4.29               
  CYGB                                       Response to oxidative stress, oxygen transport                             NM_134268                                         3.98               
  MYOT                                       Muscle contraction                                                         NM_006790                                         3.26               
                                                                                                                                                                                             
  Signal transduction and regulation         WIF1                                                                       Wnt receptor signaling pathway                    NM_007191          70.19
  PTN                                        Transmembrane receptor protein signaling pathway                           NM_002825                                         38.17              
  WNT5A                                      Oncogenesis, embryogenesis                                                 NM_003392                                         13.68              
  NCAM1                                      Neurite outgrowth, synaptic plasticity                                     NM_181351                                         7.87               
  NCAM2                                      Neurite outgrowth, synaptic plasticity                                     NM_004540                                         7.38               
  RASGRF2                                    Induction of apoptosis by extracellular signals                            NM_006909                                         6.88               
  CHN1                                       Signal transduction                                                        NM_001822                                         6.56               
  MET                                        Cell surface receptor linked signaling pathway                             NM_001127500                                      3.01               
                                                                                                                                                                                             
  Cell regulation and proliferation          SCIN                                                                       Negative regulation of cell proliferation         NM_001112706       58.65
  RELN                                       Cell morphogenesis involved in differentiation                             NM_005045                                         49.12              
  NES                                        Structural organization of the cell                                        NM_006617                                         15.67              
  MEGF10                                     Phagocytosis                                                               NM_032446                                         9.89               
  EPCAM                                      Positive regulation of cell proliferation                                  NM_002354                                         8.79               
  PDGFD                                      Positive regulation of cell division                                       NM_025208                                         5.43               
  CLU                                        Cell death, positive regulation of cell proliferation                      NM_001831                                         5.19               
  VEGFC                                      Angiogenesis, positive regulation of neuroblast proliferation              NM_005429                                         3.74               
  MSI2                                       Stem cell development                                                      NM_138962                                         3.55               
  DBC1                                       Cell cycle arrest, cell death                                              NM_014618                                         3.32               
  TGFB1                                      Cell growth, cell proliferation, cell differentiation and apoptosis        NM_000660                                         3.14               
  IGFBP6                                     Regulation of cell growth                                                  NM_002178                                         3.07               
                                                                                                                                                                                             
  Cytokine, chemokine, and immune response   IGJ                                                                        Immune response                                   NM_144646          22.65
  IGHD                                       Immune response                                                            BC021276                                          11.30              
  CXCL14                                     Chemotaxis, immune response, inhibiting angiogenesis                       NM_004887                                         8.74               
  SELE                                       Leukocyte migration involved in inflammatory response                      NM_000450                                         5.82               
  MX1                                        Induction of apoptosis, defense response, response to virus                NM_002462                                         5.24               
  IFI44                                      Response to virus                                                          NM_006417                                         5.05               
  CX3CL1                                     Chemotaxis, defense response, immune response                              NM_002996                                         3.60               
  CFI                                        Innate immune response                                                     NM_000204                                         3.17               

[^1]: Academic Editor: Boon C. Heng
